Abstract
Many antiarrhythmic drugs may produce a rise in defibrillation threshold. Mexiletine is a frequently used antiarrhythmic drug in patients with an implantable cardioverter defibrillator, usually thought of as producing no or minimal effects on the defibrillation threshold. The current case report presents a patient with an endocardial implantable cardioverter defibrillator being treated with mexiletine, which precluded the ability to defibrillate the patient.
Original language | English |
---|---|
Pages (from-to) | 507-508 |
Number of pages | 2 |
Journal | PACE - Pacing and Clinical Electrophysiology |
Volume | 25 |
Issue number | 4 I |
DOIs | |
State | Published - 1 Jan 2002 |
Keywords
- Defibrillation threshold
- Implantable defibrillator
- Mexiletine
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine